TrialScientific reports2021

A phase 2a clinical study on the safety and efficacy of individualized dosed mebendazole in patients with advanced gastrointestinal cancer.

S Mansoori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.